TREPROSTINIL PHARMACOGENOMICS AND TREATMENT RESPONSE IN PATIENTS WITH PULMONARY HYPERTENSION.

被引：0
|
作者：
Coons, J. C. [1 ]
Crisamore, K. [1 ]
Adams, S. M. [1 ]
Modany, A. [1 ]
Simon, M. A. [1 ]
Empey, P. E. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-035
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [31] Pulmonary vascular response in relatives of patients with idiopathic pulmonary arterial hypertension. An echocardiographic study
    Pavelescu, A.
    Retailleau, K.
    Huez, S.
    Vachiery, J. L.
    Naeije, R.
    EUROPEAN HEART JOURNAL, 2008, 29 : 521 - 521
  • [32] Sildenafil and tadalafil: A new option in the treatment of patients with pulmonary arterial hypertension.
    Konorza, T
    Haude, M
    Katz, M
    Neudorf, U
    Erbel, R
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 193E - 193E
  • [33] Inhaled treprostinil for pulmonary hypertension
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (2): : 64 - 65
  • [34] PHARMACOGENOMIC ANALYSIS OF TREPROSTINIL TREATMENT DOSE AND RESPONSE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION USING WHOLE GENOME SEQUENCING.
    Crisamore, K.
    Empey, P.
    Simon, M.
    Coons, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S51 - S51
  • [35] Subcutaneous treprostinil: a new treatment for chronic thromboembolic pulmonary hypertension?
    Ghofrani, Hossein-Ardeschir
    LANCET RESPIRATORY MEDICINE, 2019, 7 (03): : 191 - 193
  • [36] The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
    Kedzierski, Piotr
    Banaszkiewicz, Marta
    Florczyk, Michal
    Pilka, Michal
    Manczak, Rafal
    Wieteska-Milek, Maria
    Szwed, Piotr
    Kasperowicz, Krzysztof
    Wrona, Katarzyna
    Darocha, Szymon
    Torbicki, Adam
    Kurzyna, Marcin
    BIOMEDICINES, 2025, 13 (01)
  • [37] Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension
    Voswinckel, Robert
    Reichenberger, Frank
    Gall, Henning
    Schmehl, Thomas
    Gessler, Tobias
    Schermuly, Ralph Theo
    Grimminger, Friedrich
    Rubin, Lewis J.
    Seeger, Werner
    Ghofrani, Hossein A.
    Olschewski, Horst
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2009, 22 (01) : 50 - 56
  • [38] Cardiopulmonary response to exercise before and after pulmonary vasodilator therapy in patients with pulmonary arterial hypertension.
    Oudiz, RJ
    Yasunobu, Y
    Hansen, J
    Sun, X
    Wasserman, K
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S377 - S377
  • [39] Endothelin levels in scleroderma patients with pulmonary hypertension.
    Steen, VD
    Fertig, N
    Medsger, TA
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S130 - S130
  • [40] Pharmacokinetic evaluation of treprostinil (oral) for the treatment of pulmonary arterial hypertension
    Hellawell, Jennifer L.
    Bhattacharya, Sanjeeb
    Farber, Harrison W.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (10) : 1445 - 1453
12345